Publicaciones en colaboración con investigadores/as de Universidad de Buenos Aires (11)

2020

  1. Non-contact wide-angled visualization with chandelier-assisted scleral buckling for primary uncomplicated rhegmatogenous retinal detachment

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 258, Núm. 9, pp. 1857-1861

2019

  1. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial

    American Journal of Ophthalmology, Vol. 207, pp. 279-287

  2. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema

    Ocular Immunology and Inflammation, Vol. 27, Núm. 2, pp. 294-302

2018

  1. Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture

    Asia-Pacific Journal of Ophthalmology, Vol. 7, Núm. 1, pp. 36-39

2017

  1. Intravitreal bevacizumab for proliferative diabetic retinopathy: Results from the pan-American collaborative retina study Group (Pacores) at 24 months of follow-up

    Retina, Vol. 37, Núm. 2, pp. 334-343

2016

  1. Intravitreal Bevacizumab for Choroidal Neovascularization in age-related macular degeneration

    Retina, Vol. 36, Núm. 5, pp. 859-867

2014

  1. Outcomes of cataract surgery in diabetic patients: Results of the pan american collaborative retina study group

    Arquivos Brasileiros de Oftalmologia, Vol. 77, Núm. 6, pp. 355-359

2013

  1. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: Results of the pan-american collaborative retina study group at 24 months

    Retina, Vol. 33, Núm. 2, pp. 403-413

2010

  1. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: Results of the pan american collaborative retina study group at 24 months

    Retina, Vol. 30, Núm. 7, pp. 1002-1011

2009

  1. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: Results of the Pan American collaborative retina study group at 24 months

    Retina, Vol. 29, Núm. 10, pp. 1396-1403

  2. Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema. The Pan-American Collaborative Retina Study Group at 24 Months

    Ophthalmology, Vol. 116, Núm. 8